Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
July 4, 2007
Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis
J R Wingard, R Herbrecht, J Mauskopf, et al.
Chest
|
February 12, 2000
Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique
M G Cochrane, M V Bala, K E Downs, et al.
Health Services Research
|
October 1, 1994
Patterns of ambulatory care for AIDS patients, and association with emergency room use
J Mauskopf, B J Turner, L E Markson, et al.
British Journal of Anaesthesia
|
March 9, 2004
Patient preferences for acute pain treatment
T J Gan, D A Lubarsky, E M Flood, et al.
The Journal of Antimicrobial Chemotherapy
|
February 25, 2005
Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients
R Wenzel, A Del Favero, C Kibbler, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
April 10, 2013
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
D Husereau, M Drummond, S Petrou, et al.
HIV Medicine
|
January 27, 2005
Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients
U H Iloeje, Y Yuan, G L'italien, et al.
International Journal of Technology Assessment in Health Care
|
October 1, 1996
Results of the economic evaluation of the first study. A multinational prospective economic evaluation. FIRST Investigators. Flolan International Randomized Survival Trial
K A Schulman, M Buxton, H Glick, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
January 11, 2022
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
D Husereau, M Drummond, F Augustovski, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
July 4, 2007
Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis
J R Wingard, R Herbrecht, J Mauskopf, et al.
Chest
|
February 12, 2000
Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique
M G Cochrane, M V Bala, K E Downs, et al.
Health Services Research
|
October 1, 1994
Patterns of ambulatory care for AIDS patients, and association with emergency room use
J Mauskopf, B J Turner, L E Markson, et al.
British Journal of Anaesthesia
|
March 9, 2004
Patient preferences for acute pain treatment
T J Gan, D A Lubarsky, E M Flood, et al.
The Journal of Antimicrobial Chemotherapy
|
February 25, 2005
Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients
R Wenzel, A Del Favero, C Kibbler, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
April 10, 2013
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
D Husereau, M Drummond, S Petrou, et al.
HIV Medicine
|
January 27, 2005
Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients
U H Iloeje, Y Yuan, G L'italien, et al.
International Journal of Technology Assessment in Health Care
|
October 1, 1996
Results of the economic evaluation of the first study. A multinational prospective economic evaluation. FIRST Investigators. Flolan International Randomized Survival Trial
K A Schulman, M Buxton, H Glick, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
January 11, 2022
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
D Husereau, M Drummond, F Augustovski, et al.
Page
of 3